The application of genomics technology for analysis of liquid biopsy samples is rapidly growing. In particular, cell-free DNA (cfDNA) is the analyte that has the potential to reveal detailed information on disease progression.
Tune in to our 3-part video series
Anna Babayan, Illumina
Mariela Cuadras, Illumina
Tina Moser, MedUni Graz
Your email address is never shared with third parties.